News Provided By
October 22, 2024, 16:46 GMT
Rockville, MD, United States, October 22, 2024 — On Demand Pharmaceuticals (ODP), a pioneering leader in agile distributed medicine manufacturing, is thrilled to announce the appointment of Jarrod Borkat, MBA, as Chief Strategy and Commercial Officer, effective October 21, 2024. Jarrod brings more than two decades of experience in strategic leadership and commercialization, including senior roles at AstraZeneca and Boehringer Ingelheim, where he successfully drove innovation and growth in the pharmaceutical industry.
Jarrod joins ODP at a critical juncture as the company prepares to commercialize its groundbreaking platform for on-demand medicine manufacturing. This innovative technology enables healthcare providers to produce patient-ready generic sterile injectables at the point of care, addressing persistent challenges in drug shortages and supply chain vulnerabilities.
“We are delighted to welcome Jarrod to ODP as we enter this exciting phase of growth,” said Matt Pietras, Chief Executive Officer and Chief Financial Officer of ODP. “His extensive experience at global pharmaceutical companies, combined with his proven ability to launch and scale innovative healthcare solutions, makes him uniquely qualified to lead our commercialization efforts. Jarrod’s leadership will be instrumental in bringing our agile medicine-making capabilities to the market and transforming the way medications are produced and delivered.”
During his tenure at AstraZeneca and Boehringer Ingelheim, Jarrod held leadership positions in strategy, business development, and global commercial leadership. He has a proven track record of forging strategic partnerships, launching successful products, and driving growth in competitive markets. His expertise and vision align perfectly with ODP’s mission to revolutionize pharmaceutical manufacturing and ensure timely access to critical medications.
About On Demand Pharmaceuticals:
On Demand Pharmaceuticals™ is an innovative technology company transforming how medicines are manufactured and delivered by enabling on-demand production—whenever and wherever they are needed. Our first groundbreaking commercial product under development, the Shortage Response Pharmacy on Demand (PoD)™, focuses on addressing critical drug shortages. The PoD™ platform technology can be rapidly customized to produce anything from key starting materials and active pharmaceutical ingredients (API) to final formulated drugs. Our mission is to ensure an adequate, safe, and reliable supply of medicines to every community across the globe.
For media inquiries, please contact:
On Demand Pharmaceuticals
301-701-6998